Document:

EX-10.1

 Exhibit 10.1 

AMENDMENT AGREEMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT 

This Amendment Agreement No.1 to Securities Purchase Agreement (this “Amendment Agreement”) is entered into as of
February 8, 2016, by and between Great Basin Scientific, Inc., a Delaware corporation (the “Company”), and the investor (the “Holder”) which is one of the investors listed on the Schedule of Buyers
(“Schedule of Buyers”) attached to that certain Securities Purchase Agreement between the Company and all of the investors listed on the Schedule of Buyers (the “Buyers”) dated December 28, 2015 (the
“SPA”), with reference to the following facts: 
 A. On December 28, 2015, the Company and the Buyers
entered into the SPA in relation to the issuance and sale by the Company and purchase by the Buyers of: (i) that aggregate principal amount of senior secured convertible notes of the Company, in substantially the form attached to the SPA as
Exhibit A (the “Notes”), set forth opposite such Buyer’s name in column (3) on the Schedule of Buyers (which aggregate principal amount of Notes for all Buyers was $22,100,000) and (ii) related Series D
Warrants, in substantially the form attached to the SPA as Exhibit B (the “Warrants”), representing the right to acquire that number of shares of common stock of the Company, par value $0.0001 (“Common
Stock”), set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers (as exercised, collectively, the “Warrant Shares”), which totaled in the aggregate 3,503,116 Warrant Shares. 

B. The issuance of the Notes and the Warrants occurred at a closing on December 30, 2015 (the “Closing Date”).

 C. Section 3(c) of the SPA provides that the Company has reserved 120,000,000 of its authorized shares of common stock
(the “Initial Required Reserved Amount”) for issuance as Conversion Shares and Warrant Shares under the Notes and Warrants, respectively, and Section 4(l) provides that so long as any of the Buyers owns any Securities (as
defined in the SPA), the Company shall at all times maintain the Initial Required Reserve Amount or such additional number of shares of common stock as shall from time to time be necessary to effect the conversion of all of the Notes and the
exercise of all of the Warrants then outstanding (in each case, without regard to any limitations on conversions or exercises) (the “Required Reserve Amount”). 

D. Section 4(p) of the SPA provides that the Company shall hold a special or annual meeting of its stockholders
(“Stockholder Meeting”) not later than sixty-five (65) calendar days after the Closing Date (the “Stockholder Meeting Deadline”), which date is March 4, 2016, to hold a vote on those certain matters
related to the Notes and the Warrants as set forth in Section 4(p) of the SPA. 
 E. The Company desires to complete a
public offering of its shares of common stock and common stock purchase warrants pursuant to the terms set forth in the Company’s Registration Statement on Form S-1 (333-201596) (the “Public Financing”) but requires that the
number of shares of common stock reserved under the Initial Required Reserved Amount be reduced so that the Company has sufficient authorized, unreserved shares of common stock to complete the Public Financing. 

 F. The Holder believes that it is in the Holder’s best interests as a holder of securities
of the Company that the Company completes the Public Financing. 
 G. The Company desires more time to hold the Stockholder Meeting and
complete the filing of its definitive proxy statement and solicit proxies in relation to the Stockholder Meeting and Holder believes that it is in Holder’s best interests that the Company have more time to hold the Stockholder Meeting. 

H. In compliance with Section 9(e) of the SPA, this Agreement shall only be effective upon the execution and delivery of this
Agreement and agreements in form and substance identical to this Agreement (the “Other Agreements”, and together with this Agreement, the “Agreements”) by other holders of Registrable Securities (as defined in the
SPA) (each an “Other Holder”) representing on the Closing Date at least fifty-one percent (51%) of the aggregate number of Registrable Securities issued or issuable under the Cash Notes and Cash Warrants issued on the Closing
Date and shall include Hudson Bay so long as Hudson Bay and/or any of its affiliates collectively hold at least five percent (5%) of the Registrable Securities, in the aggregate (the “Required Holders”) (such time, the
“Effective Time”).  
 NOW, THEREFORE, in consideration of the premises set forth above, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
 1. Initial
Required Reserved Amount. 
 a. Section 3(c) of the SPA is hereby amended such that (i) from the Effective Time through
11:59:59 pm New York time on March 31, 2016, the Initial Required Reserved Amount as defined in such section shall mean 85,000,000 shares of Common Stock duly authorized and reserved for issuance as Conversion Shares and Warrants Shares and
(ii) from and after 12:00:00 am New York time on April 1, 2016, the Initial Required Reserved Amount as defined in such section shall mean 120,000,000 shares of Common Stock duly authorized and reserved for issuance as Conversion Shares
and Warrants Shares. 
 b. Section 4(l) of the SPA, Section 11(a) of the Notes and Section 1(g) of the Warrants, to the
extent they reference the defined term “Initial Required Reserved Amount” (as defined in the SPA) are hereby amended to reference such term as amended pursuant to Section 1(a) hereof. 

c. If upon the closing of the Public Offering, the price per share of common stock sold or deemed sold in the Public Offering would result in
the Public Offering being a Dilutive Issuance (as defined under the Notes) and would result in the Conversion Price (as defined in the Notes) being reduced pursuant to Section 7(a) of the Notes resulting in the Required Reserve Amount being a
higher number of shares of common stock than the Initial Required Reserved Amount, then the Holder hereby agrees that (i) only from the Effective Time through 11:59:59 pm New York time on March 31, 2016, the Required Reserve Amount under
the SPA, the Notes and the Warrants shall be equal to the Initial Required Reserve Amount and there shall be no Authorized Share Failure (as defined in the Notes and Warrants, respectively) 

  
 - 2 - 

 
under the Notes or the Warrants during such period of time and (ii) from and after 12:00:00 am New York time on April 1, 2016, the Holder waives any right to contest or otherwise attempt to
prevent the issuance of shares of common stock upon the exercise of pre-funded Series F warrants sold in the Public Offering even if there is an Authorized Share Failure under the terms of the Notes and Warrants and (iii) for the avoidance of doubt,
from and after 12:00:00 am New York time on April 1, 2016, if the number of shares duly authorized and reserved for issuance as Conversion Shares and Warrant Shares is less than 120,000,000 shares of Common Stock or such additional number of shares
of Common Stock as shall from time to time be necessary to effect the conversion of all of the Notes and the exercise of all of the Warrants then outstanding, the Company will fail to meet the Required Reserve Amount under Section 4(l) of the SPA
and an Authorized Share Failure shall have occurred under Section 11 of the Notes and Section 1(g) the Warrants, which the Company shall be required to promptly cure pursuant to the requirements of those Sections. 

d. If the Company does not complete the Public Financing by 11:59:59 pm New York time on March 31, 2016, then the amendments as
contemplated in Section 1 of this Agreement shall no longer be valid and the provisions of the SPA, Notes and Warrants as amended in this Section 1 shall revert back to their original terms as if the amendments contemplated in this
Section 1 had never occurred. 
 2. Stockholder Meeting Deadline. Section 4(p) is amended such that the Stockholder Meeting
Deadline as defined in such section shall mean a date not later than March 31, 2016. 
 3. Acknowledgments. The Company hereby
confirms and agrees that (i) except with respect to the amendments set forth in Sections 1 and 2 above as of the Effective Time, the SPA, Notes and Warrants shall continue to be, in full force and effect; (ii) the execution, delivery and
effectiveness of this Agreement shall not operate as an amendment of any right, power or remedy of the Holder except to the extent set forth herein. As of the Effective Time, the SPA, Notes and Warrants will be deemed to be fully amended and
restated to reflect the amendments set forth in Sections 1 and 2 above. 
 4. Fees, Expenses, Taxes. Each party to this Agreement
shall bear its own expenses in connection with the transactions contemplated hereby. 
 5. Disclosure of Transactions and Other Material
Information. On or before 9:30 a.m., New York City time, on February 8, 2016, the Company shall file a Current Report on Form 8-K describing the terms of the transactions contemplated by this Agreement in the form required by the Securities
Exchange Act of 1934, as amended, and attaching a copy of the form of this Agreement as an exhibit to such Current Report on Form 8-K (including all attachments, schedules and exhibits thereto, the “8-K Filing”). From and after the
filing of the 8-K Filing with the Securities and Exchange Commission, the Holder shall not be in possession of any material, nonpublic information received from the Company, any of its Subsidiaries (as defined in the SPA) or any of their respective
officers, directors, affiliates, employees or agents, that is not disclosed in such 8-K Filing. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and each Holder or any of its affiliates, on the other hand,
shall terminate. The Company shall not, and shall cause each of its Subsidiaries and its and each of their respective officers, directors, affiliates, employees and agents, not to, provide any Holder with any material, nonpublic information
regarding the Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Holder. To the extent that the Company, any of its Subsidiaries or any of their respective officers, directors,
affiliates employees or agents delivers any material, non-public information to any Holder without such Holder’s consent, the 

  
 - 3 - 

 
Company hereby covenants and agrees that such Holder shall not have any duty of confidentiality to the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates,
employees or agents with respect to, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents not to trade on the basis of, such material, non-public information. The Company
understands and confirms that the Holder will rely on the foregoing representations in effecting transactions in securities of the Company. 

6. Representations and Warranties. 

(a) Each Holder, as to itself only, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of
the Effective Date: 
 i. Organization; Authority. The Holder is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by this Agreement. 

ii. Ownership of Holder Registrable Securities. The Holder owns and holds, both beneficially (subject to the Maximum Percentage (as
defined in the Notes and the Warrants)) and of record, the entire right, title, and interest in and to the Holder Registrable Securities free and clear of all Encumbrances (as defined below). The Holder has full power and authority to transfer and
dispose of the Holder’s Registrable Securities to the Company free and clear of any Encumbrance. There is no outstanding vote, plan, pending proposal, or other right of any Person (as defined in the SPA) to acquire all or any of the Holder
Warrants. As used herein, “Encumbrances” shall mean any security or other property interest or right, claim, lien, pledge, option, charge, security interest, contingent or conditional sale, or other title claim or retention
agreement, interest or other right or claim of third parties, whether perfected or not perfected, voluntarily incurred or arising by operation of law, and including any agreement (other than this Agreement) to grant or submit to any of the foregoing
in the future other than encumbrances by one or more brokers of the Holder and encumbrances under federal or state securities laws. 
 iii.
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Holder and constitutes the legal, valid and binding obligations of the Holder enforceable against the Holder in accordance
with its terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of
applicable creditors’ rights and remedies. 
 iv. No Conflicts. The execution, delivery and performance by the Holder of this
Agreement and the consummation by the Holder of the transactions contemplated hereby will not (I) result in a violation of the organizational documents of the Holder, (II) conflict with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Holder is a party, or (III) result in a violation of
any law, rule, regulation, order, judgment or decree 

  
 - 4 - 

 
(including federal and state securities laws) applicable to the Holder, except in the case of clauses (II) and (III) above, for such conflicts, defaults, rights or violations which would not,
individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Holder to perform its obligations hereunder. 

(b) The Company represents and warrants to the Holder that, as of the date hereof and as of the Effective Date: 

i. Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and validly existing
and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authorization to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted.

 ii. Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its
obligations under this Agreement. The execution and delivery of this Agreement by the Company, and the consummation by the Company of the transactions contemplated hereby has been duly authorized by the Company’s board of directors and no
further filing, consent or authorization is required by the Company, its board of directors, shareholders or other governing body. This Agreement has been duly executed and delivered by the Company and constitutes the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. 
 iii. No
Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby will not (I) result in a violation of the organizational documents of the
Company or any share capital of the Company, (II) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (III) result in a violation of any law, rule, regulation, order, judgment or decree (including foreign, federal and state
securities laws and regulations and the rules and regulations of the Nasdaq Capital Market and including all applicable federal laws, rules and regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of
the Company or any of its Subsidiaries is bound or affected except, in the case of clause (II) or (III) above, to the extent that such violations could not reasonably be expected to have a material adverse effect on the business, properties, assets,
liabilities, operations, results of operations, condition (financial or otherwise) or prospects of the Company and its Subsidiaries, taken as a whole, or on the transactions contemplated hereby or by the agreements and instruments to be entered into
in connection herewith, or on the authority or ability of the Company to perform any of its obligations hereunder. 
 iv. Consents.
Neither the Company nor any of its Subsidiaries is required to obtain any consent from, authorization or order of, or make any filing or registration 

  
 - 5 - 

 
with any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its respective obligations
contemplated hereby. All consents, authorizations, orders, filings and registrations which the Company or any Subsidiary is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof (or in
the case of filings, will be made timely after the date hereof), and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting any
of the registrations, applications or filings contemplated hereby. “Governmental Entity” means any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal, state, local,
municipal, foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal), multi-national organization or body; or
body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature. 

7. Independent Nature of Holder Obligations and Rights. The obligations of the Holder under this Agreement are several and not joint
with the obligations of any Other Holder, and the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder under any Other Agreement. Nothing contained herein or in any Other Agreement, and no action
taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holder and Other Holders are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any Other Agreement and the Company acknowledges that the Holders are not acting in concert or as a group with respect to such
obligations or the transactions contemplated by this Agreement or any Other Agreement. The Company and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated hereby with the advice of
its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or, any Other Agreement, and it shall not be necessary for any Other
Holder to be joined as an additional party in any proceeding for such purpose. 
 8. No Third Party Beneficiaries. This Agreement is
intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 

9. Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts,
each of which when so executed and delivered shall be deemed to be an original and all of which taken together shall constitute but one and the same instrument. In the event that any signature is delivered by facsimile transmission or by an e-mail
which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and
effect as if such signature page were an original thereof. 

  
 - 6 - 

 10. No Strict Construction. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 
 11.
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. 

12. Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a
court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of
such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof
and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would
otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the
prohibited, invalid or unenforceable provision(s). 
 13. Amendments. No provision of this Agreement may be amended other than by an
instrument in writing signed by the Company and the Holder. 
 14. Further Assurances. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions contemplated hereby. 
 15. Notice. Whenever notice is required
to be given under this Agreement, unless otherwise provided herein, such notice shall be given in accordance with Section 9(f) of the SPA. 

16. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns. 
 17. Capitalized Terms. Capitalized terms used herein and not otherwise defined herein shall have the
respective meaning set forth in the SPA. 
 18. Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction,
validity, enforcement and interpretation of this Amendment Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York
or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City
of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction 

  
 - 7 - 

 
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Amendment Agreement and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AMENDMENT AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

[Signature Pages Follow] 

  
 - 8 - 

 IN WITNESS WHEREOF, each Undersigned and the Company have caused their respective
signature page to this Amendment Agreement to be duly executed as of the date first written above. 
  

					
	COMPANY:
	
	GREAT BASIN SCIENTIFIC, INC.
		
	By:	 	  

		 	Name:	 	Ryan Ashton
		 	Title:	 	President, CEO

 [Signature Page to Amendment Agreement] 

 IN WITNESS WHEREOF, each Undersigned and the Company have caused their respective
signature page to this Amendment Agreement to be duly executed as of the date first written above. 
  

					
	HOLDER:
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	Aggregate number of Registrable Securities held by the Holder (without regard to any limitation on exercise or conversion set forth therein):
	
	  

 [Signature Page to Amendment Agreement]EX-10.1

 Exhibit 10.1 

SEPARATION AGREEMENT AND RELEASE 

This Separation Agreement and Release (“Agreement”) is made and entered into this 7th day of February, 2016 (the “Effective
Date”), by and among Brixmor Property Group, Inc., a Maryland corporation (“Brixmor”), and Michael Carroll (“Executive”) (collectively, the “Parties” or each individually a “Party”). 

WHEREAS, Executive has served Brixmor as its Chief Executive Officer and member of the Board of Directors; 

WHEREAS, Executive and Brixmor are parties to an Employment Agreement dated November 1, 2011 (the “Employment
Agreement”); and 
 WHEREAS, Executive and Brixmor have agreed that Executive will terminate his employment relationship and
resign from all positions with Brixmor and all of its directly and indirectly owned subsidiaries and affiliates, including all employment, officer and board of directors and other positions, under the terms and conditions of this Agreement. 

NOW, THEREFORE, AND IN CONSIDERATION of the mutual promises of the Parties, the receipt and sufficiency of which are hereby
acknowledged, the Parties agree as follows: 
 1. Resignation From and Termination of Employment. Executive hereby resigns, effective
as of February 5, 2016 (the “Termination Date”) from his employment and all the offices, directorships and other positions he holds with Brixmor and all of its directly and indirectly owned subsidiaries and affiliates, including
without limitation any Board of Directors positions. Executive shall not be entitled to the receipt of any payments, severance, compensation, equity awards or other benefits from Brixmor under the Employment Agreement or otherwise other than those
expressly provided for in this Agreement. Brixmor expressly waives any requirement that Executive be required to give prior notice of his resignation. The Parties expressly waive any requirement of a written notice of termination. 

2. Termination Payments. 

(a) Accrued Compensation and Benefits. Executive shall receive the benefits that he would be entitled to receive in
Section 5(b)(iii) of the Employment Agreement. For the avoidance of doubt, the Annual Bonus shall be paid on Brixmor’s performance metrics and target level for the individual goals. 

(b) Severance. In consideration of Executive’s execution of this Agreement, Brixmor shall provide the benefits set forth in
Schedule A. 
 3. Acknowledgment of Consideration. 

(a) Executive acknowledges that once all of the consideration described in Section 2 has been provided, Executive shall have been paid
all compensation and other amounts due and owing to him from Brixmor, under this Agreement or from any other source. Executive 

 
acknowledges that the consideration described in Section 2 and the other consideration provided herein are above and beyond Brixmor’s obligation to Executive under the terms of his
employment with Brixmor and any other source of entitlement. Executive agrees that he is not entitled to and will not seek from Brixmor any further amounts, including but not limited to, any other wages, bonuses, vacation, sick pay, disability pay,
pension benefits, bonus compensation, profit sharing contributions, stock, partnership units, severance pay, or any other payment or benefit (except for 401(k) balances, or the payout of unused vacation time per Brixmor policy, which are not
affected by this Agreement, and payments due under this Agreement), from Releasees (as defined in Section 8 below). Executive shall automatically forfeit all outstanding, unvested equity awards (whether earned or unearned) with respect to
Brixmor and Brixmor Operating Partnership LP, other than those referenced in Section 2(b), as of the Termination Date. 
 (b) Executive
affirms that the terms stated herein are the only consideration for signing this Agreement and that no other representations, promises, or agreements of any kind have been made by any person or entity to cause him to sign this Agreement. Executive
has accepted the terms of this Agreement because he believes them to be fair and reasonable and for no other reason. 
 4.
Confidentiality, Intellectual Property, and Non-Solicitation. 
 (a) Confidentiality. Executive expressly represents that he
has complied with, reaffirms, and agrees to comply with, his obligations under Section 7(a) of the Employment Agreement, which survive termination of Executive’s employment. Executive agrees to keep the circumstances leading to and
negotiations of this Agreement confidential, except that he may make disclosures to his immediate family, financial advisor, or legal counsel. 

(b) Intellectual Property. Executive expressly represents that he has complied with, reaffirms, and agrees to comply with, his
obligations under Section 7(b) of the Employment Agreement, which survive termination of Executive’s employment. 
 (c)
Non-Solicitation. Executive expressly represents that he has complied with, reaffirms, and agrees to comply with, his obligations under Section 6(b) of the Employment Agreement, which survive termination of Executive’s employment.

 5. Non-Disparagement. To the maximum extent permitted by applicable law, and subject to Section 6, Executive agrees that, now
and in the future, Executive will not make, publish, or communicate to any person or entity any defamatory or disparaging statements regarding Releasees (as defined in Section 8). Executive understands that by agreeing to the provisions of this
Section, Executive is waiving rights guaranteed by the First Amendment of the United States Constitution and any State counterparts. Brixmor shall instruct its executive officers and directors to refrain from making any public communication that is
intended to criticize or disparage Executive. Nothing set forth herein shall be interpreted to prohibit either Party from making truthful statements when required by law, subpoena or court order, and/or from responding to any inquiry by any
regulatory or investigatory organization, and shall not prohibit Brixmor from making public statements in good faith in connection with the operation of its business or about matters in the public domain. 

  
 2 

 6. Executive’s Rights. This Agreement shall not limit any right to the extent such
right as a matter of law may not be limited by private agreement. This Agreement and the provisions hereof specifically do not limit in any way: (1) Executive’s right to provide information to any governmental authority, or to participate
in any government investigation; (2) Executive’s right to provide any information in response to a valid subpoena, court order, discovery request, or other legal process or as otherwise required to be provided by law;
(3) Executive’s right to enforce this Agreement; or (4) Executive’s right to file a charge with, provide information to, or participate in an investigation or proceeding conducted by a government agency (such as the Equal
Employment Opportunity Commission or National Labor Relations Board) authorized to enforce laws against unlawful conduct, provided that Section 8 does waive Executive’s right to seek, recover, or accept any monetary payments or other
individual relief connected to any agency or other action related to claims that are lawfully released in this Agreement. In the event Executive is requested or required by court or government agency order or request, or through subpoena or
discovery request, or other legal process, to disclose information that may be deemed covered or implicated by Sections 4 or 5, Executive agrees to the fullest extent allowable by law to give Brixmor, verbally and in writing (via e-mail to
steven.siegel@brixmor.com), notice no later than two days after receipt of such order, request, or process. 
 7. Specific
Performance. Executive acknowledges and agrees that Brixmor’s remedies at law for a breach or threatened breach of any of the provisions of Sections 4 or 5 of this Agreement would be inadequate and Brixmor would suffer irreparable damages
as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, Brixmor, without posting any bond, and notwithstanding the
arbitration procedure set forth in Section 15, shall be entitled, in addition to any other remedy available at law or equity, to cease making any payments or providing any benefit otherwise required by this Agreement and obtain equitable relief
in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. 

8. Release. In consideration of the severance described in Section 2(b) of this Agreement, and the other consideration contained
herein, Executive agrees to the following. 
 Except as otherwise set forth in this Agreement, to the maximum extent permitted by law,
Executive hereby releases, acquits and forever discharges Brixmor, its equity investors, its directly and indirectly owned subsidiaries and affiliates, and its and their officers, directors, agents, partners, members, managers, servants, employees,
shareholders, successors, and assigns (each, a “Releasee” and collectively, the “Releasees”), of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and
obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed, arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date
Executive executes this Agreement, including, but not limited to: all claims and demands directly or indirectly arising out of or in any way connected with the Employment Agreement and Executive’s employment with Brixmor or the termination of
that employment, including without limitation claims or demands related to salary, bonuses, incentives, commissions, stock, stock options, or any other ownership interests in 

  
 3 

 
Brixmor, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation, claims pursuant to any federal, state or local law or cause of action including,
but not limited to, the Civil Rights Act of 1964, the Civil Rights Act of 1866, the Civil Rights Act of 1991, the Family and Medical Leave Act of 1993, the Equal Pay Act, the National Labor Relations Act, the Fair Labor Standards Act, the
Immigration Reform and Control Act, the Occupational Safety and Health Act, the Worker Adjustment Retraining and Notification Act, the Uniform Services Employment and Reemployment Rights Act of 1994, the Fair Credit Reporting Act, the Sarbanes-Oxley
Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the False Claims Act, the Employee Retirement Income Security Act of 1974 (excluding claims for accrued vested benefits under any employee benefit or pension plan of
Brixmor, if any, in accordance with the terms and conditions of such plan and applicable law), the Americans with Disabilities Act of 1990, the New York Executive Law, the New York Civil Rights Law, the New York City Human Rights Law, the New York
City Local Civil Rights Restoration Act of 2005, the New York Minimum Wage Act, the New York Worker Adjustment Retraining and Notification Act, the New York Fair Credit Reporting Act, New York Labor Law, the New York City Administrative Code, and/or
the retaliation provisions of the New York Workers’ Compensation law, all of the foregoing as amended, contract (including the Employment Agreement, and which Executive acknowledges is superseded by this Agreement except where expressly
provided in this Agreement), wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing, or any other tort claim; provided, however, that nothing in this Agreement
shall be construed in any way to (1) release any claims that may not be waived by this Agreement as a matter of law; (2) release Brixmor from its obligation to indemnify Executive pursuant to Brixmor’s indemnification obligation in
Section 9(b) of the Employment Agreement; (3) release any claim by Executive against Brixmor relating to the validity or enforceability of this Agreement; or (4) prohibit Executive from exercising any non-waivable right to file a
charge with the United States Equal Employment Opportunity Commission, the National Labor Relations Board, or any other government agency (provided, however, that Executive shall not be entitled to recover any monetary damages or to obtain
non-monetary relief if the agency were to pursue any claims relating to Executive’s employment with Brixmor). 
 Executive represents
and agrees that he has not, by himself or on his behalf, instituted, prosecuted, filed, or processed any litigation, claims or proceedings against Brixmor or any Releasees. Executive agrees, to the maximum extent permitted by law, not to make or
file any lawsuits, complaints, or other proceedings against Brixmor or any Releasee or to join in any such lawsuits, complaints, or other proceedings against Brixmor or Releasees concerning any matter relating to Executive’s employment with
Brixmor or that arose on or prior to the date of this Agreement. The Parties agree that to the extent, if any, Executive may have a non-waivable right to file or participate in a claim or charge against Brixmor or Releasees, this Agreement shall not
be intended to waive such a right to file or participate. Executive further agrees, to the maximum extent permitted by law, that Executive shall not obtain, and hereby waives any right or entitlement to obtain, any relief or damages (whether legal,
monetary, equitable, or other) from such a non-waivable claim or charge, whether the same is filed by Executive or on Executive’s behalf. 

  
 4 

 9. Cooperation. 

(a) Executive agrees to make himself reasonably available to Brixmor and its directly and indirectly owned subsidiaries and affiliates to:
(1) for six months after the Effective Date, respond to questions and inquiries from Brixmor in connection with the transitioning of his responsibilities and provide information relevant to matters as to which he gained knowledge while employed
by Brixmor; and (2) assist Brixmor in connection with any pending, threatened, or anticipated litigation, proceeding, or inquiry with respect to which Brixmor reasonably determines Executive’s participation to be necessary, including but
not limited to providing assistance in relation to inquiries from the Securities and Exchange Commission. 
 (b) Executive shall not be
entitled to additional consideration for providing the cooperation required by Section 9(a). Notwithstanding the foregoing, Brixmor shall reimburse Executive for reasonable expenses (excluding attorney’s fees), if any, he incurs while
complying with Section 9(a). 
 10. Clawback. Within thirty (30) days of any of the following events, Executive shall
return to Brixmor an amount equal to the value of the award provided under Section 2(b) at the time such award was provided, and Brixmor shall have no further obligation to provide such award. 

(a) A court or government agency finally determines that Executive violated federal securities law during his employment with Brixmor; 

(b) Executive materially violates Section 9(a) and fails, after notice from Brixmor, to cure such violation promptly to the satisfaction
of Brixmor; 
 (c) Executive violates Section 8; or 

(d) Executive materially violates Section 4(a) and fails, after notice from Brixmor, to cure such violation, if curable, promptly to the
satisfaction of Brixmor. 
 11. No Admission. It is understood and agreed by both Parties that this Agreement does not constitute an
admission of liability by either Party. By entering into this Agreement, neither Party admits that it has committed any wrongdoing whatsoever. Each party expressly denies that it has engaged in any wrongdoing. 

12. Death. In the event of Executive’s death occurring on or after the Termination Date, Brixmor shall provide the amounts in
Section 2 that have not previously been paid to Executive to the beneficiary designated by Executive in writing (which designation, where applicable, shall be effected in accordance with the terms and conditions of the applicable plan documents
and procedures) or, if no such beneficiary shall be named or be living at the time of his death, to his estate. 
 13. Withholding.
All payments to be made to or benefits to be received by Executive under this Agreement shall be subject to withholding to satisfy required withholding taxes and other required deductions. 

  
 5 

 14. Choice of Law. The terms of this Agreement shall be governed by the laws of the State
of New York. 
 15. Arbitration. Any disputes arising under or in connection with this Agreement shall be resolved by binding
arbitration, to be held in New York, New York in accordance with the Employment Arbitration Rules, as amended from time to time, of the American Arbitration Association (the “AAA”). Brixmor and Executive will each select an arbitrator, and
a third arbitrator will be selected jointly by the arbitrators selected by Brixmor and Executive within 15 days after demand for arbitration is made by a Party. If the arbitrators selected by the Brixmor and Executive are unable to agree on a third
arbitrator within that period, then either the Brixmor or Executive may request that the AAA select the third arbitrator. The arbitrators will possess substantive legal experience in the principal issues in dispute and will be independent of Brixmor
and Executive. To the extent permitted by applicable law and not prohibited by Brixmor’s certificate of incorporation and bylaws, the Parties shall equally bear the fees and expenses of the arbitrators and the AAA and the Parties shall bear
their own costs and attorneys’ fees. Except as may otherwise be agreed in writing by the Parties or as ordered by the arbitrators upon substantial justification shown, the hearing for the dispute will be held within 60 days of submission of the
dispute to arbitration. The arbitrators will render their final award within 30 days following conclusion of the hearing and any required post-hearing briefing or other proceedings ordered by the arbitrators. The arbitrators will state the factual
and legal basis for the award. The decision of the arbitrators will be final and binding, subject to judicial review as permitted by law, and final judgment may be entered upon such an award in any court of competent jurisdiction, but entry of such
judgment will not be required to make such award effective. Notwithstanding the foregoing, claims brought by Brixmor under Section 7 may be brought in any state or federal court of competent jurisdiction where there is proper venue, and
Executive agrees and submits to the exclusive jurisdiction of any such court for such claims. 
 16. Waiver of Jury Trial. THE
PARTIES HEREBY WAIVE TRIAL BY JURY AS TO ANY AND ALL FUTURE LITIGATION BETWEEN THEM, INCLUDING ANY CLAIMS AND/OR DISPUTES ARISING OUT OF OR RELATING TO THIS AGREEMENT OR EXECUTIVE’S EMPLOYMENT WITH BRIXMOR. 

17. Compliance with Code Section 409A. 

(a) The intent of the Parties is that payments and benefits under this Agreement comply with or be exempt from Code Section 409A and,
accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. Notwithstanding any provision of this Agreement to the contrary, neither Brixmor nor any other Releasee shall have any liability to
Executive or to any other person or entity if any payments or benefits under the Agreement are not so compliant or exempt. 
 (b) A
termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits that are considered nonqualified deferred compensation under Code Section 409A
upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A, and, for purposes of any such provision of this Agreement, references to a
“termination,” “termination of employment” or like terms shall 

  
 6 

 
mean “separation from service.” The determination of whether and when a separation from service has occurred for proposes of this Agreement shall be made in accordance with the
presumptions set forth in Section 1.409A-1(h) of the Treasury Regulations. 
 (c)
Notwithstanding any provision of this Agreement to the contrary, if at the time of Executive’s separation from service, Brixmor determines that Executive is a “specified employee,” within the meaning of Code Section 409A, then to
the extent any payment or benefit that Executive becomes entitled to under this Agreement on account of such separation from service would be considered nonqualified deferred compensation under Code Section 409A, such payment or benefit shall
be paid or provided at the date which is the earlier of (i) six (6) months and one day after such separation from service and (ii) the date of Executive’s death (the “Delay Period”). Upon the expiration of the Delay
Period, all payments and benefits delayed pursuant to this Section 17 (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or provided to Executive in a lump-sum, without interest, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. 

18. Notice. For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing
and shall be deemed to have been duly given when delivered by e-mail, hand, or overnight courier or three days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective
addresses set forth below in this Agreement, or to such other address as either Party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

If to Brixmor: 
 Brixmor
Property Group, Inc., 450 Lexington Avenue, 13th Floor, New York, NY 10017 
 Attention: General Counsel (steven.siegel@brixmor.com) 

with a copy (which shall not constitute notice) to: 

Hogan Lovells US LLP, 555 Thirteenth Street, NW, Washington, DC 20004 Attention: Michael E. McTiernan (michael.mctiernan@hoganlovells.com) 

If to Executive: 
 To the
most recent contact information of Executive set forth in the personnel records of Brixmor. 
 19. Miscellaneous. 

(a) Entire Agreement. This Agreement contains and constitutes the entire understanding and agreement between the Parties on its subject
matter, and, except as otherwise expressly provided herein, it supersedes and cancels all previous negotiations, agreements, commitments, and writings in connection herewith, including without limitation the Employment Agreement. Notwithstanding the
foregoing, Brixmor’s 2013 Omnibus Incentive Plan (as amended from time to time) and the award agreement governing each equity award that vests pursuant to this Agreement shall continue to apply to the extent the provisions do not conflict with
this Agreement, and the Amended and Restated Agreement of Limited Partnership of 

  
 7 

 
Brixmor Operating Partnership LP (as amended from time to time) shall continue to govern the LTIP Units that vest pursuant to this Agreement. If a conflict or inconsistency is found between the
terms of this Agreement and any other agreement, the terms of this Agreement shall prevail. 
 (b) Amendment and Waiver. This
Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms hereof may be waived, only by a written instrument signed by the Parties or, in the case of a waiver, by the Party waiving compliance. No delay on the part
of any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any Party of any such right, power or privilege nor any single or partial exercise of any such right, power or
privilege, preclude any other or further exercise thereof or the exercise of any other such right, power or privilege. 
 (c)
Severability. Invalidity or unenforceability of any provision of this Agreement shall in no way affect the validity of enforceability of any other provision. 

(d) Assignability. This Agreement and Executive’s rights and obligations under this Agreement may not be assigned by Executive
without the prior written consent of Brixmor. Brixmor may assign, with or without Executive’s consent, this Agreement and its rights and obligations under this Agreement to any entity affiliated with it or to any successor entity. 

(e) Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors,
permitted assigns, heirs, executors and legal representatives. 
 (f) Counterparts. This Agreement may be executed in counterparts,
both of which taken together will constitute one and the same Agreement. This Agreement may be executed and delivered by facsimile transmission of signed counterparts or in .pdf or similar format by electronic mail transmission, and in any number of
counterparts, each of which shall be deemed an original, with the same effect as if the signatures thereto and hereto were upon the same instruments. 

(g) Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement. 

(h) SEC Filing. The Parties acknowledge and agree that this Agreement will be filed by Brixmor with the United States Securities and
Exchange Commission. 
 (i) Expenses. Each of the Parties shall bear its own costs and expenses, including, without limitation,
attorneys’ fees relating to or arising from the negotiation and execution of this Agreement. 
 (j) Definitions. Capitalized
terms not defined herein have the meanings assigned to them in the Employment Agreement. 
 (k) Joint Work Product. This Agreement
shall be deemed the joint work product of the Parties hereto and their respective counsel, including legal counsel, and each of the Parties shall be considered the drafters of this Agreement. Any rule of construction to the effect that any
ambiguities are to be construed against the drafting party shall not be applicable in any interpretation of this Agreement. 
 (l)
Non-Compete Waived. Brixmor agrees to waive Executive’s obligations under Section 6(a) of the Employment Agreement. 

  
 8 

 20. Acknowledgements. The Parties affirm that they have carefully read the terms of this
Agreement, that they know and understand the contents and meaning of this Agreement and that they sign this Agreement as a matter of their own free acts and after consultation with their own legal counsel. The Parties further agree that this
Agreement shall be deemed the joint work product of the Parties hereto and their respective counsel, including legal counsel, and each of the Parties shall be considered the drafters of this Agreement. Any rule of construction to the effect that any
ambiguities are to be construed against the drafting party shall not be applicable in any interpretation of this Agreement. This Agreement shall become effective on the Effective Date. 

[Signature Page Follows] 

  
 9 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date set forth below.

  

			
	BRIXMOR PROPERTY GROUP, INC.
		
	By:	 	 /s/ Steven F. Siegel

		 	Steven F. Siegel
		 	Executive Vice President
		
	Date:	 	February 7, 2016
	
	 /s/ Michael Carroll

	Michael Carroll
	
	Date: February 7, 2016

  
 10 

 SCHEDULE A 

In consideration of Executive’s execution of the Separation Agreement and Release and other promises by Executive, Executive shall receive the following
benefits (less applicable withholdings in accordance with Section 13 of the Agreement), which except as otherwise noted, shall be vested, paid to, or transferred to, as applicable, Executive as soon as administratively practicable following the
Effective Date, but in no event sooner than the expiration of the Delay Period in accordance with Section 17 of the Agreement, if applicable, or later than March 15, 2017: 

 

	 	1.	42,500 LTIP Units of Brixmor Operating Partnership LP shall vest, which represents the number of LTIP Units that Executive will be deemed to be entitled to receive with respect to outstanding 2014 Tranche 2 LTIP Unit
awards, the performance period for which has already closed, assuming a target achievement of performance, non-satisfaction of individual goals, and acceleration of time-based vesting, plus an additional number of LTIP Units shall be granted,
which number shall equal the Dividend Earned Units (as defined in the applicable award agreement) as of the Termination Date for each 2014 Tranche 2 LTIP Unit that vests pursuant to this Agreement (such additional number of LTIP Units to be
calculated by Brixmor, in its sole and absolute discretion); and 

  

	 	2.	36,954 LTIP Units of Brixmor Operating Partnership LP shall vest, which represents the number of LTIP Units that Executive will be deemed to be entitled to receive with respect to outstanding 2015 Tranche 1 LTIP Unit
awards, the performance period for which has already closed, assuming a target achievement of performance, non-satisfaction of individual goals, and acceleration of time-based vesting, plus an additional number of LTIP Units shall be granted,
which number shall equal the Dividend Earned Units (as defined in the applicable award agreement) as of the Termination Date for each 2015 Tranche 1 LTIP Unit that vests pursuant to this Agreement (such additional number of LTIP Units to be
calculated by Brixmor, in its sole and absolute discretion). 

  

	 	3.	17,000 LTIP Units of Brixmor Operating Partnership LP, related to outstanding 2014 Tranche 3 LTIP Unit awards, will remain unvested but will not be forfeited, and will vest on December 31, 2016 assuming the
company-wide strategic objective, which has been achieved as of the date of this Agreement, continues to be achieved as of December 31, 2016, plus an additional number of LTIP Units shall be granted, which number shall equal the Dividend
Earned Units (as defined in the applicable award agreement) as of December 31, 2016 (such additional number of LTIP Units to be calculated by Brixmor, in its sole and absolute discretion). 

For the avoidance of doubt, other than as set forth in this Schedule A, as of the Termination Date, Executive shall forfeit all of his outstanding, unvested
equity awards (whether earned or unearned) with respect to Brixmor or Brixmor Operating Partnership LP.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]